FDA approves first non-opioid treatment for opioid withdrawal

18 May, 2018, 09:28 | Author: Andrea Terry
  • FDA Approves Lofexidine Hydrochloride, First Non-Opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

For people who have been diagnosed with opioid use disorder, withdrawal management alone, with or without Lucemyra, is not recommended; Lucemyra should be used as part of a long-term treatment plan created by a healthcare provider.

The non-opioid tablets can be used for up to two weeks.

The approval of WorldMed's Lucemyra was expedited in an effort to combat the opioid epidemic.

For those addicted to opioids, quitting cold turkey can be a harrowing experience. It treats narcotic withdrawal symptoms like vomiting, muscle aches, diarrhea, anxiety, sleep problems and sweats.

In patients using opioid analgesics appropriately as prescribed, opioid withdrawal is typically managed by slow taper of the medication, which is meant to avoid or lessen the effects of withdrawal while allowing the body to adapt to not having the opioid.

Gottlieb said the FDA wants to "strike the right balance" between making policies that give patients who need opioids the proper accessibility and preventing opioid exposures that lead to new addictions. And those who seek assistance may relapse due to continued withdrawal symptoms.


Developed under private company US WorldMeds, Lucemyra works by diminishing the release of norepinephrine, a neurotransmitter that relays feelings of pain and affects withdrawal symptoms, research suggests.

The safety and efficacy was supported by 2 randomized, double-blind, placebo-controlled clinical trials of 866 adults meeting Diagnostic and Statistical Manual-IV criteria for opioid dependence who were physically dependent on opioids and undergoing abrupt opioid discontinuation. Compared to placebo, Short Opiate Withdrawal Scale of Gossop scores were found to be lower for patients treated with Lucemyra, and more patients finished the treatment in the Lucemyra group versus the placebo group.

The FDA has requested 15 post-marketing studies, in both animals and humans, to support longer-term use of the drug and use in children or adolescents under 17. This committee received public input from patients who use opioids to manage their chronic pain. It is not approved as a treatment for opioid use disorder.

In patients utilizing opioid analgesics fittingly as endorsed, opioid withdrawal is regularly overseen by a moderate decrease of the prescription, which is planned to dodge or reduce the impacts of withdrawal while enabling the body to adjust to not having the opioid. Some patients received Lucemyra, and some patients received a placebo.

The new compound itself is not without side effects; Lucemyra can cause dizziness as well as low blood pressure and heart rate. "The actions of norepinephrine in the autonomic nervous system are believed to play a role in numerous symptoms of opioid withdrawal", the FDA said.

Recommended:



Popular

What Macy's Got Right in Q1
Comparable sales on an owned basis were up 3.9 percent in the first quarter and up 4.2 percent on an owned plus licensed basis. Further, it has been operating in a friendly economy environment, marked by strong consumer sentiment and spending, he said.

Uber Sexual Assault Victims No Longer Forced Into Arbitration
If this approach survives court challenges, it could limit the potential payout for lawyers and damages that Uber could face. Jeanne Christensen, the attorney representing the women who wrote the letter, says the change caught her by surprise.

Armenia's New Leader Pashinyan Meets Putin, Seeks Deeper Military Ties With Russia
Nikol Pashinian, an opposition figure who spearheaded weeks of nationwide protests, was elected by parliament last week. According to the press statement of the Armenian government, the two PMs have agreed to meet in the near future.

Taliban Attack Tests Afghan Forces Near Iran Border
In 2017 insurgents tried three times to overrun the capital, according to the Afghanistan Analysts Network. They have been posting images on social media which they claim shows them inside the city.

Trump cedes global leadership by pulling out of Iran nuclear deal
Though the president says he wants to negotiate a new deal, the United States has nearly no leverage to pull that off. This article has been adapted from its original source . "As the president said, we are ready for all options".

Jerusalem embassy: Ivanka Trump and Jared Kushner arrive for Monday opening
The weekly protests along the Israel-Gaza border are expected to culminate on Monday in parallel to the celebrations in Jerusalem. Forty-two Palestinians have been killed and over 1,800 have been wounded by Israeli fire since weekly protests began on March 30.

Former PM Mahathir Mohamad storms back to power in Malaysia
He was spurred out of retirement by allegations that Najib oversaw the wide-scale looting of sovereign wealth fund 1MDB. Anwar is in prison on corruption and sodomy charges that were widely denounced as politically motivated.

Manchester United vs Watford: Potential XI for Michael Carrick's swansong
Richarlison and Gerard Deulofeu will hope for recalls after being left out of the starting XI for their last match. So far the identity of the player leaving Old Trafford has not been revealed but it could be Anthony Martial.

Novak Djokovic dumped out of Madrid Open by Britain's Kyle Edmund
Meanwhile, second-seed Caroline Wozniacki was taken to three sets by Ashleigh Barty but eventually prevailed 6-2, 4-6, 6-4. I tried but obviously, yeah, wasn't to be to today. "I try to always remind myself and be grateful of that".

Has Donald Trump Jr. Already Moved On from Vanessa Trump?
The eldest son of Donald Trump is now dating Fox News host, Kimberly Guilfoyle , 49, according to Page Six . Guilfoyle , who hosts " The Five " on Fox News , was previously married to current California Lt.